Aflac Earnings Preview: What to Expect
Aflac (AFL) is scheduled to report Q2 earnings on Aug. 6, 2026 after the close. Analysts expect diluted EPS of $1.77 versus $1.78 a year ago. For fiscal 2026, consensus EPS is $7.07, down from $7.49 in 2025. AFL stock is up 21.9% over 52 weeks; consensus rating is Hold with an average target of $117.20.
How this was made
The 30-second read
Why it matters
Traders can benchmark expectations against consensus EPS for Q2 ($1.77) and FY26 ($7.07) and position for potential upside/downside if results or commentary diverge.
Market read
This is an expectations-and-timing setup for the Aug. 6 earnings print, not a disclosure of new fundamentals.
What to watch
The preview does not discuss guidance details, investment income, or loss-ratio drivers, which are often the real swing factors for insurer earnings reactions.
Background
Aflac is a supplemental health and life insurer with operations in the U.S. and Japan, and it is scheduled to report Q2 earnings after the close on Aug. 6, 2026.
Ticker impact
Article previews Aflac’s Q2 earnings on Aug. 6 and cites consensus EPS $1.77 and FY26 EPS $7.07 expectations.
Near-term volatility risk around the Aug. 6 after-close release versus the $1.77 EPS and FY26 $7.07 consensus.
The piece provides specific consensus EPS levels and timing, but it does not disclose any new company-specific development beyond expectations.
Market effects
Limited read-across for insurers; this is primarily a single-name earnings setup with no new sector datapoint.
Minimal, as the article does not introduce new regional macro or regulatory developments.
Low, despite Japan operations mention, because no new Japan-specific catalyst is provided.
Counterpoint
If Aflac’s steady cash generation and buybacks continue to support results, the stock could outperform even with a modest EPS decline versus the year-ago quarter.
Key entities
- companyAflac Incorporated
Subject of the earnings preview, scheduled to report Q2 earnings on Aug. 6, 2026.


